Shares of Metlife Inc (NYSE:MET) have been assigned an average recommendation of “Hold” from the twelve research firms that are currently covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and five have issued a buy rating on the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $49.51.
Several equities research analysts have recently issued reports on MET shares. B. Riley reaffirmed a “neutral” rating on shares of Metlife in a research report on Tuesday, October 15th. ValuEngine raised Metlife from a “strong sell” rating to a “sell” rating in a research report on Saturday, December 21st. UBS Group raised their price target on Metlife from $46.00 to $47.00 and gave the company a “neutral” rating in a research report on Thursday, October 10th. Wells Fargo & Co reaffirmed a “buy” rating on shares of Metlife in a research report on Monday. Finally, Morgan Stanley raised Metlife from an “equal weight” rating to an “overweight” rating and raised their price target for the company from $55.00 to $60.00 in a research report on Tuesday.
Several large investors have recently modified their holdings of MET. Resources Management Corp CT ADV bought a new stake in shares of Metlife in the third quarter valued at about $26,000. Venturi Wealth Management LLC bought a new stake in shares of Metlife in the third quarter valued at about $37,000. Kings Point Capital Management bought a new stake in shares of Metlife in the second quarter valued at about $50,000. Quest Capital Management Inc. ADV bought a new stake in shares of Metlife in the third quarter valued at about $47,000. Finally, Allworth Financial LP lifted its stake in shares of Metlife by 37.9% in the third quarter. Allworth Financial LP now owns 1,095 shares of the financial services provider’s stock valued at $52,000 after buying an additional 301 shares during the period. 74.47% of the stock is currently owned by institutional investors.
Metlife (NYSE:MET) last posted its earnings results on Wednesday, October 30th. The financial services provider reported $1.27 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.40 by ($0.13). The business had revenue of $16.92 billion for the quarter, compared to analyst estimates of $16.37 billion. Metlife had a return on equity of 8.82% and a net margin of 10.82%. The company’s quarterly revenue was up 3.2% compared to the same quarter last year. During the same period in the previous year, the company earned $1.38 earnings per share. As a group, research analysts predict that Metlife will post 5.53 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, March 13th. Stockholders of record on Tuesday, February 4th will be given a $0.44 dividend. This represents a $1.76 annualized dividend and a dividend yield of 3.35%. The ex-dividend date is Monday, February 3rd. Metlife’s dividend payout ratio is currently 32.65%.
Metlife Company Profile
MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
Featured Story: How to Invest in an Index Fund
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.